Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Improved quantification for local regions of interest in preclinical PET imaging.

Cal-González J, Moore SC, Park MA, Herraiz JL, Vaquero JJ, Desco M, Udias JM.

Phys Med Biol. 2015 Sep 21;60(18):7127-49. doi: 10.1088/0031-9155/60/18/7127. Epub 2015 Sep 3.

2.

Bone marrow dosimetry using 124I-PET.

Schwartz J, Humm JL, Divgi CR, Larson SM, O'Donoghue JA.

J Nucl Med. 2012 Apr;53(4):615-21. doi: 10.2967/jnumed.111.096453. Epub 2012 Mar 13.

3.

dAcquisition setting optimization and quantitative imaging for 124I studies with the Inveon microPET-CT system.

Anizan N, Carlier T, Hindorf C, Barbet J, Bardiès M.

EJNMMI Res. 2012 Feb 13;2:7. doi: 10.1186/2191-219X-2-7.

4.

124I-huA33 antibody uptake is driven by A33 antigen concentration in tissues from colorectal cancer patients imaged by immuno-PET.

O'Donoghue JA, Smith-Jones PM, Humm JL, Ruan S, Pryma DA, Jungbluth AA, Divgi CR, Carrasquillo JA, Pandit-Taskar N, Fong Y, Strong VE, Kemeny NE, Old LJ, Larson SM.

J Nucl Med. 2011 Dec;52(12):1878-85. doi: 10.2967/jnumed.111.095596. Epub 2011 Nov 8.

5.

Quantitative imaging of 124I and 86Y with PET.

Lubberink M, Herzog H.

Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S10-8. doi: 10.1007/s00259-011-1768-2. Epub 2011 Apr 12. Review.

6.

Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Nayak TK, Brechbiel MW.

Bioconjug Chem. 2009 May 20;20(5):825-41. doi: 10.1021/bc800299f. Review.

7.

124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.

Sundaresan G, Yazaki PJ, Shively JE, Finn RD, Larson SM, Raubitschek AA, Williams LE, Chatziioannou AF, Gambhir SS, Wu AM.

J Nucl Med. 2003 Dec;44(12):1962-9.

Supplemental Content

Support Center